Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Bachem Holding AG (BANB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9769
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and biotechnology industries. Bachem’s research products include biologically active peptides, amino acid derivatives, biochemicals and immunology products. It also provides active pharmaceutical ingredients and custom synthesis. These products and services include peptides indicated for the treatment of various conditions such as central nervous system disorders, metabolic disorders, cancer and infectious diseases, among others; research ingredients; new chemical entities; and generics. The company operates production facilities in the US and Europe. Bachem is headquartered in Bubendorf, Switzerland.

Bachem Holding AG (BANB) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bachem Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Magenta Therapeutics Enters into Development and Manufacturing Agreement with Bachem Americas 10
Cyxone Enters into Agreement with Bachem 11
Bachem and Dottikon Enter into Agreement 12
Bachem Enters into Co-Promotion Agreement with Glytech 13
Bachem Expands Co-Marketing Agreement with ILS 14
Acquisition 15
Bachem Americas Acquires American Peptide Company 15
Bachem Holding AG – Key Competitors 16
Bachem Holding AG – Key Employees 17
Bachem Holding AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Jul 20, 2018: Bachem: Footprint in Asia 19
Financial Announcements 20
Aug 24, 2018: Bachem-first half of 2018: further rise in the net profit 20
Corporate Communications 21
Oct 26, 2018: Thomas Meier to become new COO of Bachem Group 21
Other Significant Developments 22
Mar 16, 2018: Bachem: Fiscal year 2017 – Continued increase in sales, profitability and earnings 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Bachem Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Deals By Therapy Area, 2012 to YTD 2018 8
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Magenta Therapeutics Enters into Development and Manufacturing Agreement with Bachem Americas 10
Cyxone Enters into Agreement with Bachem 11
Bachem and Dottikon Enter into Agreement 12
Bachem Enters into Co-Promotion Agreement with Glytech 13
Bachem Expands Co-Marketing Agreement with ILS 14
Bachem Americas Acquires American Peptide Company 15
Bachem Holding AG, Key Competitors 16
Bachem Holding AG, Key Employees 17
Bachem Holding AG, Subsidiaries 18

List of Figures
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Acura Pharmaceuticals Inc (ACUR)-医療機器分野:企業M&A・提携分析
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • Advanced Accelerator Applications SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Advanced Accelerator Applications SA (AAA), a Novartis company, is engaged in developing, producing and commercializing diagnostic and therapeutic molecular nuclear medicine products. The company’s lead product candidate comprises Lutathera, NETSPOT, SOMAKIT TOC, Gluscan, Gluscan 500, Barnas …
  • National Life Group:企業の戦略・SWOT・財務情報
    National Life Group - Strategy, SWOT and Corporate Finance Report Summary National Life Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Clearside BioMedical Inc (CLSD):製薬・医療:M&Aディール及び事業提携情報
    Summary Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO - Retinal Vein Occlu …
  • Acura Pharmaceuticals Inc (ACUR):製薬・医療:M&Aディール及び事業提携情報
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • Liburnia Riviera Hoteli d.d.:企業の戦略・SWOT・財務情報
    Liburnia Riviera Hoteli d.d. - Strategy, SWOT and Corporate Finance Report Summary Liburnia Riviera Hoteli d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • St. George Bank:企業の戦略・SWOT・財務分析
    St. George Bank - Strategy, SWOT and Corporate Finance Report Summary St. George Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • New York Power Authority:電力:M&Aディール及び事業提携情報
    Summary New York Power Authority (NYPA) is a state-owned power organization. It generates electricity, and transmits and sells that on wholesale basis. The authority produces the electricity using hydro, gas, and oil sources. Through long-term electricity supply agreement with Astoria Energy II LLC, …
  • Synthos SA:企業の戦略的SWOT分析
    Synthos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Micron Technology Inc:企業の戦略・SWOT・財務分析
    Micron Technology Inc - Strategy, SWOT and Corporate Finance Report Summary Micron Technology Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AntriaBio Inc (ANTB)-製薬・医療分野:企業M&A・提携分析
    Summary AntriaBio Inc (AntriaBio), formerly AntriaBio Delaware Inc is a biopharmaceutical company that develops drug therapies for the treatment of diabetes and metabolic diseases. The company’s lead product candidate include AB10, human recombinant insulin for use in type 1 and type 2 diabetes for …
  • The Saudi Arabian Monetary Agency:企業の戦略的SWOT分析
    The Saudi Arabian Monetary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Broadridge Financial Solutions, Inc.:企業の戦略・SWOT・財務分析
    Broadridge Financial Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Broadridge Financial Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Allenex AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Allenex AB (Allenex), formerly LinkMed AB, a subsidiary of CareDx Inc, is a blood stemcells and organs transplantation service provider. The company offers olerup SSP and absorber. Its oleruu is used before the transplantation. Allenex offers pre transplantation, transplantation and post tra …
  • Genesis Energy LP (GEL):企業の財務・戦略的SWOT分析
    Genesis Energy LP (GEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • JD Sports Fashion Plc:企業のM&A・事業提携・投資動向
    JD Sports Fashion Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JD Sports Fashion Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • VOXX International Corporation:企業の戦略・SWOT・財務情報
    VOXX International Corporation - Strategy, SWOT and Corporate Finance Report Summary VOXX International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Hess Corporation (HES)-エネルギー分野:企業M&A・提携分析
    Summary Hess Corporation (Hess) is a global independent energy company which carries out the exploration and production of crude oil and natural gas. It primarily operates in US, Denmark, Equatorial Guinea, the Joint Development Area of Malaysia/Thailand (JDA), Malaysia, and Norway. It offers fee-ba …
  • Sernova Corp (SVA):企業の財務・戦略的SWOT分析
    Sernova Corp (SVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Berger Paints India Ltd (BERGEPAINT):企業の財務・戦略的SWOT分析
    Berger Paints India Ltd (BERGEPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆